Clinical Trial Results

Showing: All studies [change]
Condition: Diabetes 25 trials found
New Search
Filter
Trial Phase
Study Type
Mechanisms of Fatigability With Diabetes
NAINTERVENTIONAL Ann Arbor, Michigan
RECRUITING
Breaking up Sedentary Time to Improve Glucose Control in a Population at Risk for Developing Type 2 Diabetes
EARLY_PHASE1INTERVENTIONAL Aurora, Colorado
RECRUITING
The Role of Type 2 Diabetes on Skeletal Muscle Atrophy and Recovery Following Bed Rest in Older Adults
NAINTERVENTIONAL Orlando, Florida
RECRUITING
Glycemic Metrics and Patterns in People With and Without Prediabetes
N/AOBSERVATIONAL Bend, Oregon
RECRUITING
Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
N/AOBSERVATIONAL Aurora, Colorado +1 more
RECRUITING
Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
PHASE2INTERVENTIONAL New Haven, Connecticut
RECRUITING
Effect of Exercise and/or Liraglutide on Vascular Dysfunction and Insulin Sensitivity in Type 2 Diabetes ( ZQL007)
PHASE4INTERVENTIONAL Charlottesville, Virginia
RECRUITING
The RESET System Pivotal Clinical Trial (Protocol Revision K)
NAINTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
CGM Academy for Youth With Type 1 Diabetes
NAINTERVENTIONAL Los Angeles, California
RECRUITING
Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes
EARLY_PHASE1INTERVENTIONAL Nashville, Tennessee
RECRUITING
Behavioral Approaches to Reduce Diabetes Distress in Adults With Type 1 Diabetes: A Pragmatic SMART
NAINTERVENTIONAL Chapel Hill, North Carolina
RECRUITING
iGlucose® Remote Patient Monitoring Device as an Adjunct to Routine Glucose Meter Devices for Glycemic Management and Control in Gestational Diabetes
NAINTERVENTIONAL Houston, Texas
RECRUITING
Brain Health in Youth With Normal Weight, Overweight and Obesity at Risk for Type 2 Diabetes (T2D)
N/AOBSERVATIONAL St Louis, Missouri +1 more
RECRUITING
A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
PHASE3INTERVENTIONAL Sacramento, California +4 more
RECRUITING
Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
PHASE3INTERVENTIONAL San Diego, California +4 more
RECRUITING
A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults
PHASE3INTERVENTIONAL Santa Barbara, California +4 more
RECRUITING
A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes (BARICADE-PRESERVE)
PHASE3INTERVENTIONAL Aurora, Colorado +4 more
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
PHASE3INTERVENTIONAL New Haven, Connecticut +4 more
RECRUITING
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes
PHASE3INTERVENTIONAL Paramus, New Jersey +1 more
RECRUITING
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type